Abstract: BrainXell's human neuron culture platforms provide a means to model the human brain in a dish and perform in vitro functional assays. This system enables the screening of disease phenotypes and pharmacological agents that alter neuronal activity. In the case of neurotoxicity, it is critical to use in vitro systems that more closely model the human nervous system and its response to environmental toxins. Such a platform provides greater predictive power to indicate which compounds pose a risk. Toward this goal, we have developed an assay centered on the use of BrainXell’s iPSC derived human cortical neurons and the spontaneous calcium oscillations that occur once mature networks have formed. These oscillations represent the changes in calcium concentration that are closely tied to neuronal activity as action potentials invoke large pre synaptic calcium influx and also cause a notable rise in postsynaptic calcium at excitatory synapses Fluorescent measurements of calcium oscillations can be achieved with calcium sensitive dyes that have high signal to noise ratio, efficient cellular loading, and good intracellular retention, and the oscillations are observed spontaneously when culturing neurons under suitable conditions to form mature networks. Such oscillations are reflective of a population of neurons having synchronous network activity. Using this assay, we assessed 12 potentially seizurogenic and toxic compounds and identified various ways in which they impact the spontaneous calcium oscillations. Compounds that target glutamatergic neurotransmission, GABAergic neurotransmission, and voltage gated potassium channels each had distinct effects on the spontaneous calcium oscillations. Moreover, changes were concentration dependent and were observed at low concentrations known to modulate the targets.Summary: BrainXell's human neuron culture platforms provide a means to model the human brain in a dish and perform in vitro functional assays. This system enables the screening of disease phenotypes and pharmacological agents that alter neuronal activity.
Ask the author a question about this poster.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Quantitative systems pharmacology model of amyloid and tau to explore efficacy of therapy targeting modified forms of amyloid
Immunity Buster Herbal Plant: During Covid-19 Pandemic
FuGENE SI: A novel and efficient siRNA transfection reagent with minimal cellular toxicity.
Tony Larsen, Douglas Grunwald, Chris Sherrill, and James Prudent
Effectiveness of structured motor retraining program in adults with traumatic brachial plexus injury under gone nerve transfer- A case report
Subin Solomen, Jimshad TU, Dr Sreejith K, Dr Pradeep
Monoclonal antibody therapy efficacy can be boosted by combinations with other treatments: predictions from integrated Alzheimer’s disease QSP platform
Tatiana Karelina, Stepan Lerner